Ultimovacs Receives FDA Orphan Drug Designation for the UV1 Cancer Vaccine for Treatment of Mesothelioma -October 09, 2023 at 01:01 am EDT : vimarsana.com

  The orphan drug designation was granted based on data from the randomized Phase II clinical trial NIPU The results from the NIPU study will be presented at the ESMO Congress being held October...

Related Keywords

Oslo , Norway , Spain , Denmark , Sweden , Germany , Madrid , Australia , Norwegian , Bristol Myers Squibb , Office Of Orphan Products Developments , Professor At Oslo University Hospital , Oslo University Hospital , Drug Administration , Halle University , Astrazeneca , International Agency For Research On Cancer Globocan , Orphan Drug Designation , Principal Investigator , Oslo University , Carlos De Sousa , Orphan Products Developments , International Agency , Human Leukocyte Antigen , Abuse Regulation , Norwegian Securities Trading , Markets ,